(Q64378216)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492081%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

review article

1 reference

title

Gene therapy for head and neck cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492081%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

1 reference

head and neck carcinoma

1 reference

1 reference

Douglas K Frank

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492081%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

English

0 references

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492081%20AND%20SRC:MED&resulttype=core&format=json

Surgical oncology clinics of North America

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492081%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492081%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492081%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

589-606, vi-vii

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492081%20AND%20SRC:MED&resulttype=core&format=json

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21).

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Adenovirus-mediated gene therapy for head and neck squamous cell carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Interleukin-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H mice

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Limitations of adenovirus-mediated interleukin-2 gene therapy for oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

HSV-tk gene therapy in head and neck squamous cell carcinoma. Enhancement by the local and distant bystander effect

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Human adenovirus vectors for gene transfer into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Improved cationic lipid formulations for in vivo gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Cationic liposome-mediated transfection.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Drug-carrier potential of liposomes in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Mutations and altered expression of p16INK4 in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Optimizing suicide gene therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Bystander tumoricidal effect in the treatment of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Cancer gene therapy: a bystander effect using the gap junctional pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Gap junctional intercellular communication and carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Immunology of head and neck cancer: perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Perilymphatic injections of recombinant interleukin-2 (rIL-2) partially correct the immunologic defects in patients with advanced head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Interleukin-2 toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Immunomodulation therapy for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Biological-clinical significance of selective loss of HLA-class-I allelic product expression in squamous-cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

HLA class I and class II antigen expression on squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Gene therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Inhibition of cell proliferation in head and neck squamous cell carcinoma cell lines with antisense cyclin D1

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

The actions of retinoids on cellular growth correlate with their actions on gap junctional communication

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Retinoid-enhanced gap junctional communication is achieved by increased levels of connexin 43 mRNA and protein

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900021-2

7 January 2021

10.1016/S1055-3207(02)00021-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492081%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference